Overview
Roper Technologies, Inc., based in the United States, is a diversified technology company primarily engaged in the development of software, products, and solutions for a variety of niche markets. It operates through four main segments: Application Software, Network Software & Systems, Measurement & Analytical Solutions, and Process Technologies. Roper Technologies focuses on high-growth sectors where its products and solutions can significantly enhance customer productivity. Key projects typically involve strategic acquisitions that broaden its technological capabilities and market reach. Recent acquisitions have strengthened its presence in healthcare IT, transportation, food, energy, water, education, and legal sectors. Roper’s business model emphasizes sustainable organic growth and maintaining high margins through strategic customer relationships and a lean operating structure.
Basic Stats
The share price of Roper Technologies, Inc. as of September 5, 2025 is $518.52 / share. This is a decrease of -1.48% from the prior week. The market cap (or net worth) of Roper Technologies, Inc. as of September 5, 2025 is $55,792.75 MM.
The Factor Analysis chart (below right) shows a view of Roper Technologies, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 55,792.75 MM |
| EV | 64,409.35 MM |
| Shares Out. | 107.60 MM |
| Earnings Date | |
| EPS (TTM) | 14.31 |
| Dividend Yield | 0.58 % |
| Ex-Dividend Date | 2025-10-03 |
| Borrow Rate | 0.25 |
| Short Shares Avail. | 1.40 MM |
| Short Interest | 1.40 MM |
| Short Float | 1.31 % |
| Days to Cover | 2.87 days |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | -6.56 % |
| Volatility (1 yr) | 0.20 |
| Beta | 0.71 |
| Sharpe Ratio (1 yr) | -0.54 |
| Sortino Ratio (1 yr) | -0.88 |
| PE Ratio | 36.24 |
| Price/Book | 2.84 |
| Price/TBV | -5.31 |
| Book/Market | 0.35 |
| EBIT/EV | 0.03 |
| EBIT(3yr avg)/EV | 0.03 |
| ROA | 0.05 |
| ROE | 0.08 |
| ROIC | 0.05 |
| CROIC | -0.00 |
| OCROIC | 0.08 |
| Implied Volatility | 19.16 % |
| Put/Call OI Ratio | 0.39 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Roper Technologies, Inc. is $647.43. The forecasts range from a low of $469.88 to a high of $738.15. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Roper Technologies, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-01-30 | RBC Capital | Outperform | Maintains | |
| 2023-01-30 | Barclays | Overweight | Maintains | |
| 2022-07-25 | RBC Capital | Outperform | Maintains | |
| 2022-04-27 | RBC Capital | Outperform | Maintains | |
| 2021-02-01 | JP Morgan | Underweight | Maintains | |
| 2020-09-08 | JP Morgan | Neutral | Underweight | Downgrade |
| 2020-07-29 | Raymond James | Outperform | Maintains | |
| 2020-07-07 | Barclays | Equal-Weight | Maintains | |
| 2020-06-12 | Oppenheimer | Outperform | Perform | Downgrade |
| 2020-04-29 | Argus Research | Buy | Maintains | |
| 2020-03-16 | Wells Fargo | Overweight | Maintains | |
| 2020-01-31 | Wells Fargo | Overweight | Maintains | |
| 2020-01-31 | RBC Capital | Outperform | Maintains | |
| 2019-10-10 | JP Morgan | Neutral | Maintains | |
| 2019-08-27 | RBC Capital | Outperform | Maintains | |
| 2019-07-09 | Barclays | Equal-Weight | Maintains | |
| 2019-07-03 | Raymond James | Outperform | Maintains | |
| 2019-04-30 | Stephens & Co. | Overweight | Overweight | Maintains |
| 2022-12-15 | Goldman Sachs | Neutral | Maintains | |
| 2022-10-27 | Wells Fargo | Overweight | Maintains | |
| 2021-12-17 | Mizuho | Buy | Initiate | |
| 2015-07-28 | JP Morgan | Neutral | Maintains | |
| 2021-04-08 | Oppenheimer | Outperform | Maintains | |
| 2021-04-06 | Barclays | Overweight | Maintains | |
| 2019-04-26 | Argus Research | Buy | Buy | Maintains |
| 2015-09-11 | JP Morgan | Neutral | Underweight | Downgrade |
| 2022-07-25 | Wells Fargo | Overweight | Maintains | |
| 2022-06-23 | Goldman Sachs | Neutral | Maintains | |
| 2021-12-15 | Wolfe Research | Peer Perform | Initiate | |
| 2021-10-25 | RBC Capital | Outperform | Maintains | |
| 2021-10-04 | Raymond James | Outperform | Strong Buy | Upgrade |
| 2021-07-26 | RBC Capital | Outperform | Maintains | |
| 2021-07-26 | Barclays | Overweight | Maintains | |
| 2021-06-30 | Oppenheimer | Outperform | Maintains | |
| 2021-04-28 | RBC Capital | Outperform | Maintains | |
| 2021-03-18 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2015-04-28 | JP Morgan | Neutral | Maintains | |
| 2015-04-28 | Canaccord Genuity | Hold | Maintains | |
| 2015-04-28 | Barclays | Overweight | Maintains | |
| 2015-03-17 | Barclays | Overweight | Maintains | |
| 2015-01-27 | JP Morgan | Neutral | Maintains | |
| 2015-01-15 | JP Morgan | Neutral | Maintains | |
| 2014-11-25 | RBC Capital | Outperform | Initiate | |
| 2014-10-06 | Barclays | Overweight | Maintains | |
| 2014-07-29 | Citigroup | Buy | Maintains | |
| 2014-07-29 | Barclays | Overweight | Maintains | |
| 2014-05-08 | Barclays | Overweight | Maintains | |
| 2014-04-29 | Canaccord Genuity | Hold | Maintains | |
| 2014-01-28 | Barclays | Overweight | Maintains | |
| 2013-03-27 | Canaccord Genuity | Hold | Initiate | |
| 2013-03-18 | Citigroup | Buy | Maintains | |
| 2013-01-31 | JP Morgan | Neutral | Maintains | |
| 2013-01-29 | Barclays | Overweight | Maintains | |
| 2012-11-16 | Citigroup | Neutral | Buy | Upgrade |
| 2012-09-10 | JP Morgan | Neutral | Maintains | |
| 2012-09-05 | Citigroup | Neutral | Maintains | |
| 2012-08-06 | JP Morgan | Neutral | Maintains | |
| 2022-10-27 | Barclays | Overweight | Maintains | |
| 2022-07-26 | Cowen & Co. | Outperform | Maintains | |
| 2022-07-25 | Barclays | Overweight | Maintains | |
| 2022-07-08 | Barclays | Overweight | Maintains | |
| 2022-05-24 | Barclays | Overweight | Maintains | |
| 2021-03-17 | Oppenheimer | Perform | Outperform | Upgrade |
| 2021-02-02 | Argus Research | Buy | Maintains | |
| 2019-04-26 | Raymond James | Outperform | Outperform | Maintains |
| 2019-04-03 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2019-02-04 | Wells Fargo | Outperform | Outperform | Maintains |
| 2019-02-04 | Baird | Neutral | Neutral | Maintains |
| 2018-12-17 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2018-11-20 | Stephens & Co. | Overweight | Initiate | |
| 2018-10-29 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2018-09-21 | JP Morgan | Overweight | Neutral | Downgrade |
| 2018-08-02 | Argus | Buy | Buy | Maintains |
| 2018-07-27 | Raymond James | Strong Buy | Outperform | Downgrade |
| 2018-07-27 | JP Morgan | Overweight | Overweight | Maintains |
| 2018-05-22 | JP Morgan | Overweight | Overweight | Maintains |
| 2018-04-24 | JP Morgan | Overweight | Overweight | Maintains |
| 2018-04-23 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2018-02-15 | Barclays | Equal-Weight | Initiate | |
| 2018-02-05 | Canaccord Genuity | Hold | Hold | Maintains |
| 2017-10-31 | Baird | Neutral | Maintains | |
| 2017-09-20 | JP Morgan | Neutral | Overweight | Upgrade |
| 2017-02-23 | Argus Research | Buy | Upgrade | |
| 2017-02-23 | Argus | Hold | Buy | Upgrade |
| 2017-01-13 | JP Morgan | Neutral | Overweight | Upgrade |
| 2017-01-06 | Oppenheimer | Perform | Outperform | Upgrade |
| 2016-10-19 | Argus Research | Hold | Initiate | |
| 2016-10-19 | Argus | Hold | Initiate | |
| 2016-08-01 | JP Morgan | Underweight | Neutral | Upgrade |
| 2016-07-27 | JP Morgan | Underweight | Maintains | |
| 2016-07-20 | Raymond James | Strong Buy | Initiate | |
| 2016-02-02 | Stifel Nicolaus | Buy | Maintains | |
| 2016-02-02 | Barclays | Overweight | Maintains | |
| 2016-01-19 | Barclays | Overweight | Maintains | |
| 2022-01-11 | Bernstein | Market Perform | Initiate | |
| 2015-11-25 | Stifel Nicolaus | Buy | Initiate | |
| 2015-10-12 | Cowen & Co. | Outperform | Initiate | |
| 2015-10-12 | Barclays | Overweight | Maintains | |
| 2015-10-05 | Barclays | Overweight | Maintains | |
| 2023-02-23 | Wolfe Research | Peer Perform | Outperform | Upgrade |
| 2023-03-20 | Truist Securities | Buy | Initiate | |
| 2023-03-22 | RBC Capital | Outperform | Reiterate | |
| 2023-03-22 | JP Morgan | Underweight | Neutral | Upgrade |
| 2023-03-23 | Mizuho | Neutral | Reiterate | |
| 2023-05-01 | Barclays | Overweight | Maintains | |
| 2023-05-11 | RBC Capital | Outperform | Outperform | Reiterate |
| 2023-05-02 | TD Cowen | Outperform | Maintains | |
| 2023-05-02 | Bernstein | Market Perform | Outperform | Upgrade |
| 2023-06-27 | Jefferies | Buy | Initiate | |
| 2023-07-25 | TD Cowen | Outperform | Outperform | Maintains |
| 2023-10-26 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-04-02 | Barclays | Overweight | Overweight | Maintains |
| 2023-07-24 | Argus Research | Buy | Buy | Maintains |
| 2023-07-24 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-07-24 | Oppenheimer | Outperform | Outperform | Maintains |
| 2023-07-24 | Barclays | Overweight | Overweight | Maintains |
| 2023-07-24 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-07-25 | Raymond James | Strong Buy | Strong Buy | Maintains |
| 2024-03-22 | Oppenheimer | Outperform | Outperform | Maintains |
| 2023-10-20 | Truist Securities | Buy | Buy | Reiterate |
| 2023-10-26 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-10-26 | Mizuho | Neutral | Neutral | Maintains |
| 2024-02-02 | Raymond James | Strong Buy | Strong Buy | Maintains |
| 2024-02-01 | Oppenheimer | Outperform | Outperform | Reiterate |
| 2024-02-01 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-02-01 | Mizuho | Neutral | Neutral | Maintains |
| 2024-04-29 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-04-29 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-02-05 | Barclays | Overweight | Overweight | Maintains |
| 2024-01-22 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-04-29 | Mizuho | Neutral | Neutral | Maintains |
| 2024-01-04 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-01-04 | TD Cowen | Outperform | Market Perform | Downgrade |
| 2024-06-13 | Wolfe Research | Outperform | Peer Perform | Downgrade |
| 2024-07-10 | Barclays | Overweight | Overweight | Maintains |
| 2025-04-29 | JP Morgan | Neutral | Neutral | Maintains |
| 2025-04-29 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-04-29 | Stifel | Buy | Buy | Maintains |
| 2025-04-29 | Baird | Outperform | Outperform | Maintains |
| 2025-01-28 | TD Cowen | Hold | Buy | Upgrade |
| 2024-08-27 | Truist Securities | Buy | Buy | Reiterate |
| 2025-03-27 | Stifel | Buy | Initiate | |
| 2025-01-31 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-08-16 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-08-16 | Jefferies | Buy | Buy | Maintains |
| 2025-05-16 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-07-25 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-07-25 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-07-25 | Baird | Neutral | Outperform | Upgrade |
| 2024-10-17 | Mizuho | Neutral | Neutral | Maintains |
| 2024-12-05 | Barclays | Overweight | Underweight | Downgrade |
| 2025-01-31 | Truist Securities | Buy | Buy | Reiterate |
| 2025-01-31 | Raymond James | Strong Buy | Strong Buy | Reiterate |
| 2025-01-31 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-10-24 | Truist Securities | Buy | Buy | Reiterate |
| 2024-10-24 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-10-24 | Baird | Outperform | Outperform | Maintains |
| 2025-01-08 | Barclays | Underweight | Underweight | Maintains |
| 2025-04-08 | JP Morgan | Neutral | Neutral | Maintains |
| 2025-05-05 | William Blair | Outperform | Initiate | |
| 2025-07-22 | Truist Securities | Buy | Buy | Maintains |
| 2025-07-22 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-07-22 | JP Morgan | Neutral | Neutral | Maintains |
| 2025-07-22 | Baird | Outperform | Outperform | Maintains |
| 2025-08-20 | Citigroup | Buy | Initiate |
